• Nature reviews. Neurology · Sep 2014

    Parkinson disease: Can a new trial end controversy over when to use levodopa?

    • Olivier Rascol.
    • Clinical Investigation Centre CIC1436, Departments of Clinical Pharmacology and Neurosciences, INSERM and Toulouse University Hospital, University of Toulouse 3, Place du Docteur Baylac, TSA 40031, 31059 Toulouse CEDEX 9, France.
    • Nat Rev Neurol. 2014 Sep 1; 10 (9): 488-9.

    AbstractLevodopa is the standard therapy for Parkinson disease, but prolonged use promotes the development of adverse motor effects. A new trial compared the effectiveness of levodopa administration early in the disease with therapies that used alternative dopaminergic agents before levodopa. No clinically relevant differences were found between the treatment strategies.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…